ArticleHuman vaccines & immunotherapeutics2025
Impact of HPV vaccination on the hospitalizations for anogenital warts and high-grade cervical intraepithelial neoplasia in Brazil: A national analysis.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Premature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023.Human vaccines & immunotherapeutics · 2026Article
- Early effects of HPV vaccination on high-grade cervical intraepithelial neoplasia in Brazil: Evidence from outpatient data.Human vaccines & immunotherapeutics · 2026Article
- Assessing the burden of HPV-associated cancers in Brazil: Hospitalization and mortality trends from 2011 to 2019.Human vaccines & immunotherapeutics · 2026Article
- Gender-neutral human papillomavirus vaccination: an equitable and cost-effective public health investment.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The HPV vaccination program in Brazil, introduced in 2014 for girls and 2017 for boys, aims to reduce HPV-related diseases, including anogenital warts (AGW) and high-grade cervical intraepithelial neoplasia (CIN). This descriptive ecological study evaluated the program's impact on hospitalizations for AGW and high-grade-CIN using interrupted time series analysis of data from the Brazilian Hospital Information System from 2011 to 2019. From 2011 to 2019, there were 4,312 AGW hospitalizations among females, 7,295 AGW hospitalizations among males, and 84,306 hospitalizations for high-grade CIN. Following the implementation of the HPV vaccination program, significant reductions in hospitalizations for AGW and high-grade CIN were observed, particularly in the targeted 15-19-year-old age group. In this group, the median number of hospitalizations prevented was 174 (95% CI: 154-193) for AGW among females, 116 (95% CI: 86-147) for AGW among males, and 217 (95% CI: 94-339) for high-grade CIN, with strong model fits. Downward trends were also noted in older age groups, though with poorer model fits. The HPV vaccination program has significantly reduced hospitalizations for AGW and high-grade CIN in Brazil, particularly among the targeted age group. Local evidence of early disease benefits reinforces the importance of HPV immunization in reducing the burden of HPV-related diseases and support expanding vaccination efforts for broader public health benefits. Reductions of AGW and high-grade CIN in older age groups may reflect indirect vaccination effects and treatment strategies, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.